Spotlight Asset Group, Inc. Sarepta Therapeutics, Inc. Call Options Transaction History

Spotlight Asset Group, Inc.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 18, 2022	SELL	$75.71 - $119.24 $757,099 - $1.19 Million	-10,000 Closed	0 $0
Q1 2021 Apr 07, 2021	SELL	$72.25 - $168.95 $722,500 - $1.69 Million	-10,000 Reduced 50.0%	10,000 $78,000
Q3 2020 Oct 30, 2020	BUY	$127.12 - $172.34 $2.54 Million - $3.45 Million	20,000 New	20,000 $15,000
Q2 2020 Jul 23, 2020	SELL	$93.0 - $171.7 $930,000 - $1.72 Million	-10,000 Closed	0 $0
Q4 2019 Apr 13, 2020	BUY	$76.53 - $135.58 $765,300 - $1.36 Million	10,000 New	10,000 $160,000

530

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Spotlight Asset Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Spotlight Asset Group, Inc. with notifications on news.